GM2/GD2 Synthase Antibodies

Santa Cruz Biotechnology delivers a wide array of GM2/GD2 Synthase monoclonal antibodies for research in understanding GM2/GD2 synthase's role in various biological processes. GM2/GD2 Synthase monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). GM2/GD2 synthase is a key enzyme involved in the biosynthesis of gangliosides, which are critical components of cell membranes and play significant roles in cell signaling, differentiation, and neurodevelopment. The regulation of GM2/GD2 synthase is essential for maintaining cellular homeostasis and has implications in various diseases, including cancer and neurodegenerative disorders. Understanding the function of GM2/GD2 synthase can provide insights into therapeutic targets and disease mechanisms. Research with GM2/GD2 Synthase monoclonal antibodies enables exploration of ganglioside biology and its impact on health and disease. GM2/GD2 Synthase monoclonal antibodies from Santa Cruz Biotechnology support researchers worldwide in advancing scientific knowledge and developing potential therapeutic strategies.